As a prelude to introducing
genes whose products would be
therapeutically useful in cancer, the researchers say they have successfully introduced a harmless
gene from bacteria into TILs without affecting the behaviour of the cells (Proceedings of the National Academy of Sciences, vol 87, p 473).